Survey of Ophthalmology
Volume 55, Issue 3 , Pages 272-283 , May 2010

Blue-blocking IOLs Decrease Photoreception Without Providing Significant Photoprotection

  • Martin A. Mainster, PhD, MD, FRCOphth

      Affiliations

    • Corresponding Author InformationReprint address: Martin A. Mainster, PhD, MD, FRCOphth, Department of Ophthalmology, University of Kansas School of Medicine, 7400 State Line Road, Prairie Village, KS 66208-3444.
    • ,
  • Patricia L. Turner, MD

References 

  1. ACGIH. Threshold limit values and biological exposure indices. Cincinnati, OH: American Conference of Governmental Industrial Hygienists; 2000;
  2. Arnarsson A, Sverrisson T, Stefansson E, et al. Risk factors for five-year incident age-related macular degeneration: the Reykjavik Eye Study. Am J Ophthalmol. 2006;142:419–428
  3. Asplund R, Ejdervik Lindblad B. The development of sleep in persons undergoing cataract surgery. Arch Gerontol Geriatr. 2002;35:179–187
  4. Asplund R, Lindblad BE. Sleep and sleepiness 1 and 9 months after cataract surgery. Arch Gerontol Geriatr. 2004;38:69–75
  5. Augustin AJ. The physiology of scotopic vision, contrast vision, color vision and circadian rhythmicity: can these parameters be influenced by blue-light-filter lenses?. Retina. 2008;28(9):1179–1187
  6. Baatz H, Darawsha R, Ackermann H, et al. Phacoemulsification does not induce neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:1079–1083
  7. Barker FM, Brainard GC. The Direct Spectral Transmittance of the Excised Human Lens as a Function of Age (FDA 785345 0090 RA). Washington, DC: U.S. Food and Drug Administration; 1991;
  8. Behndig A, Monestam E. Quantification of glistenings in intraocular lenses using Scheimpflug photography. J Cataract Refract Surg. 2009;35:14–17
  9. Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science. 2002;295:1070–1073
  10. Berson EL. Light deprivation and retinitis pigmentosa. Vision Res. 1980;20:1179–1184
  11. Boettner EA, Wolter JR. Transmission of the ocular media. Invest Ophthalmol. 1962;1:776–783
  12. Boulton M, Rozanowska M, Rozanowski B. Retinal photodamage. J Photochem Photobiol B. 2001;64:144–161
  13. Brainard GC, Hanifin JP, Greeson JM, et al. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci. 2001;21:6405–6412
  14. Braunstein RE, Sparrow JR. A blue-blocking intraocular lens should be used in cataract surgery. Arch Ophthalmol. 2005;123:547–549
  15. Cajochen C, Munch M, Kobialka S, et al. High sensitivity of human melatonin, alertness, thermoregulation, and heart rate to short wavelength light. J Clin Endocrinol Metab. 2005;90:1311–1316
  16. Campbell SS, Kripke DF, Gillin JC, et al. Exposure to light in healthy elderly subjects and Alzheimer's patients. Physiol Behav. 1988;42:141–144
  17. Carson D, Margrain TH, Patel A. Reply: Retinal photoxicity in the aging pseudophakic and phakic eye. J Cataract Refract Surg. 2009;35:210–211
  18. Centers for Medicare & Medicaid Services. Medicare program: disapproval of adjustment in payment amounts for new technology intraocular lenses furnished by ambulatory surgical centers. Federal Register. 2005;70:15337–15340
  19. Charman WN. Age, lens transmittance, and the possible effects of light on melatonin suppression. Ophthalmic Physiol Opt. 2003;23:181–187
  20. Chew EY, Sperduto RD, Milton RC, et al. Risk of advanced age-related macular degeneration after cataract surgery in the Age-related Eye Disease Study: AREDS report 25. Ophthalmology. 2009;116:297–303
  21. Clemons TE, Milton RC, Klein R, et al. Risk factors for the incidence of Advanced Age-related Macular Degeneration in the Age-related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology. 2005;112:533–539
  22. Curcio CA, Millican CL, Allen KA, et al. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest Ophthalmol Vis Sci. 1993;34:3278–3296
  23. Darzins P, Mitchell P, Heller RF. Sun exposure and age-related macular degeneration. An Australian case-control study. Ophthalmology. 1997;104:770–776
  24. De Fabo EC. Initial studies on an in vivo action spectrum for melanoma induction. Prog Biophys Mol Biol. 2006;92:97–104
  25. Delcourt C, Carriere I, Ponton-Sanchez A, et al. Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liées à l'Age (POLA) study. Arch Ophthalmol. 2001;119:1463–1468
  26. Di Cesare S, Maloney S, Fernandes BF, et al. The effect of blue light exposure in an ocular melanoma animal model. J Exp Clin Cancer Res. 2009;28:48
  27. Dickinson CM. Optical aids for low vision. In:  Charman WN editors. Visual Optics and Instrumentation. Boca Raton, FL: CRC Press, Inc; 1991;p. 183–228
  28. Dijk DJ, Neri DF, Wyatt JK, et al. Sleep, performance, circadian rhythms, and light-dark cycles during two space shuttle flights. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1647–R1664
  29. Edwards L, Torcellini P. A Literature Review of the Effects of Natural Light on Building Occupants. Golden, CO: National Renewable Energy Laboratory, U.S. Department of Energy; 2002;
  30. Enk CD, Jacob-Hirsch J, Gal H, et al. The UVB-induced gene expression profile of human epidermis in vivo is different from that of cultured keratinocytes. Oncogene. 2006;25:2601–2614
  31. Evans JR, Fletcher AE, Wormald RP. 28,000 cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking. Br J Ophthalmol. 2005;89:550–553
  32. Figueiro MG, Rea MS, Bullough JD. Does architectural lighting contribute to breast cancer?. J Carcinog. 2006;5:20
  33. Fletcher AE, Bentham GC, Agnew M, et al. Sunlight exposure, antioxidants, and age-related macular degeneration. Arch Ophthalmol. 2008;126:1396–1403
  34. Gilchrest BA, Eller MS, Geller AC, et al. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med. 1999;340:1341–1348
  35. Golden RN, Gaynes BN, Ekstrom RD, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry. 2005;162:656–662
  36. Griswold MS, Stark WS. Scotopic spectral sensitivity of phakic and aphakic observers extending into the near ultraviolet. Vision Res. 1992;32:1739–1743
  37. Gronfier C, Wright KP, Kronauer RE, et al. Entrainment of the human circadian pacemaker to longer-than-24-h days. Proc Natl Acad Sci USA. 2007;104:9081–9086
  38. Guenel P, Laforest L, Cyr D, et al. Occupational risk factors, ultraviolet radiation, and ocular melanoma: a case-control study in France. Cancer Causes Control. 2001;12:451–459
  39. Ham WT, Mueller HA, Ruffolo JJ, et al. Action spectrum for retinal injury from near-ultraviolet radiation in the aphakic monkey. Am J Ophthalmol. 1982;93:299–306
  40. Hanifin JP, Brainard GC. Photoreception for circadian, neuroendocrine, and neurobehavioral regulation. J Physiol Anthropol. 2007;26:87–94
  41. Hankins MW, Peirson SN, Foster RG. Melanopsin: an exciting photopigment. Trends Neurosci. 2008;31:27–36
  42. Hannibal J, Fahrenkrug J. Neuronal input pathways to the brain's biological clock and their functional significance. Adv Anat Embryol Cell Biol. 2006;182:1–71
  43. Hayashi K, Hayashi H. Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non-tinted intraocular lenses. Br J Ophthalmol. 2006;90:1019–1023
  44. Herljevic M, Middleton B, Thapan K, et al. Light-induced melatonin suppression: age-related reduction in response to short wavelength light. Exp Gerontol. 2005;40:237–242
  45. Hirvela H, Luukinen H, Laara E, et al. Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology. 1996;103:871–877
  46. Hyman LG, Lilienfeld AM, Ferris FL, et al. Senile macular degeneration: a case-control study. Am J Epidemiol. 1983;118:213–227
  47. Jackson GR, Owsley C, Cordle EP, et al. Aging and scotopic sensitivity. Vision Res. 1998;38:3655–3662
  48. Jackson GR, Owsley C, McGwin G. Aging and dark adaptation. Vision Res. 1999;39:3975–3982
  49. Jackson GR, Owsley C. Scotopic sensitivity during adulthood. Vision Res. 2000;40:2467–2473
  50. Jackson GR. Pilot study on the effect of a blue-light-blocking IOL on rod-mediated (scotopic) vision: American Society for Cataract and Refractive Surgery. Washington DC, 2005 Annual Meeting. April 15–20, 2005;
  51. Jahn C, Wustemeyer H, Brinkmann C, et al. Macular pigment density in age-related maculopathy. Graefes Arch Clin Exp Ophthalmol. 2005;243:222–227
  52. Jasser SA, Hanifin JP, Rollag MD, et al. Dim light adaptation attenuates acute melatonin suppression in humans. J Biol Rhythms. 2006;21:394–404
  53. Kanis MJ, Wisse RP, Berendschot TT, et al. Foveal cone-photoreceptor integrity in aging macula disorder. Invest Ophthalmol Vis Sci. 2008;49:2077–2081
  54. Keep PJ. Stimulus deprivation in windowless rooms. Anaesthesia. 1977;32:598–602
  55. Khan JC, Shahid H, Thurlby DA, et al. Age related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight. Br J Ophthalmol. 2006;90:29–32
  56. Knight JA, Thompson S, Raboud JM, et al. Light and exercise and melatonin production in women. Am J Epidemiol. 2005;162:1114–1122
  57. Lack L, Wright H. Shorter wavelength light is more effective for changing melatonin phase. Chronobiol Int. 2003;20:1179–1181
  58. Lamb LE, Simon JD. A2E: a component of ocular lipofuscin. Photochem Photobiol. 2004;79:127–136
  59. Landers JA, Tamblyn D, Perriam D. Effect of a blue-light-blocking intraocular lens on the quality of sleep. J Cataract Refract Surg. 2009;35:83–88
  60. Lee H. Introduction to Color Imaging Science. Cambridge: Cambridge University Press; 2005;
  61. Lee TM, Chan CC, Paterson JG, et al. Spectral properties of phototherapy for seasonal affective disorder: a meta-analysis. Acta Psychiatr Scand. 1997;96:117–121
  62. Lehrl S, Gerstmeyer K, Jacob JH, et al. Blue light improves cognitive performance. J Neural Transm. 2007;114:457–460
  63. Lewy AJ, Emens JS, Lefler BJ, et al. Melatonin entrains free-running blind people according to a physiological dose-response curve. Chronobiol Int. 2005;22:1093–1106
  64. Lockley SW, Skene DJ, Tabandeh H, et al. Relationship between napping and melatonin in the blind. J Biol Rhythms. 1997;12:16–25
  65. Lockley SW, Evans EE, Scheer FA, et al. Short-wavelength sensitivity for the direct effects of light on alertness, vigilance, and the waking electroencephalogram in humans. Sleep. 2006;29:161–168
  66. Lubkin V, Beizai P, Sadun AA. The eye as metronome of the body. Surv Ophthalmol. 2002;47:17–26
  67. Mainster MA. Solar retinitis, photic maculopathy and the pseudophakic eye. J Am Intraocul Implant Soc. 1978;4:84–86
  68. Mainster MA. Spectral transmittance of intraocular lenses and retinal damage from intense light sources. Am J Ophthalmol. 1978;85:167–170
  69. Mainster MA, Ham WT, Delori FC. Potential retinal hazards. Instrument and environmental light sources. Ophthalmology. 1983;90:927–932
  70. Mainster MA. The spectra, classification, and rationale of ultraviolet-protective intraocular lenses. Am J Ophthalmol. 1986;102:727–732
  71. Mainster MA. Light and macular degeneration: a biophysical and clinical perspective. Eye. 1987;1:304–310
  72. Mainster MA, Sparrow JR. How much blue light should an IOL transmit?. Br J Ophthalmol. 2003;87:1523–1529
  73. Mainster MA. Intraocular lenses should block UV radiation and violet but not blue light. Arch Ophthalmol. 2005;123:550–555
  74. Mainster MA. Violet and blue light blocking intraocular lenses: photoprotection versus photoreception. Br J Ophthalmol. 2006;90:784–792
  75. Mainster MA. Blue-blocking intraocular lenses and pseudophakic scotopic sensitivity. J Cataract Refract Surg. 2006;32:1403–1404
  76. Mainster MA, Boulton M. Retinal phototoxicity. In:  Albert DM,  Miller JW,  Blodi BA,  Azar DT editor. Principles and Practice of Ophthalmology. ed 3. London, UK: Elsevier; 2008;p. 2195–2205
  77. Mainster MA, Turner PL. Retinal phototoxicity in the aging pseudophakic and phakic eye. J Cataract Refract Surg. 2009;35:209–210
  78. Mainster MA, Turner PL. Blue-blocking intraocular lenses: myth or reality?. Am J Ophthalmol. 2009;147:8–10
  79. Mainster MA, Turner PL. Intraocular lens spectral filtering, in Steinert RF (ed). Cataract Surgery: Technique, Complications, and Management. London, UK, Saunders, ed 3, pp 477–86
  80. Mainster MA, Turner PL. Blue-blocking intraocular lenses: visual and nonvisual photoreception. Retina. 2009;29:417–420
  81. Margrain TH, Boulton M, Marshall J, et al. Do blue light filters confer protection against age-related macular degeneration?. Prog Retin Eye Res. 2004;23:523–531
  82. Marmor MF. Double fault! Ocular hazards of a tennis sunglass. Arch Ophthalmol. 2001;119:1064–1066
  83. Marshall J, Cionni RJ, Davison J, et al. Clinical results of the blue-light filtering AcrySof Natural foldable acrylic intraocular lens. J Cataract Refract Surg. 2005;31:2319–2323
  84. Marshall JC, Gordon KD, McCauley CS, et al. The effect of blue light exposure and use of intraocular lenses on human uveal melanoma cell lines. Melanoma Res. 2006;16:537–541
  85. McCarty CA, Mukesh BN, Fu CL, et al. Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol. 2001;119:1455–1462
  86. McIntyre IM, Norman TR, Burrows GD, et al. Quantal melatonin suppression by exposure to low intensity light in man. Life Sci. 1989;45:327–332
  87. Mellerio J. Light effects on the retina. In:  Albert DM,  Jakobiec FA editor. Principles and Practice of Ophthalmology. vol. 1:Philadelphia, PA, W.B: Saunders Company; 1994;p. 1326–1345
  88. Middleton B, Stone BM, Arendt J. Human circadian phase in 12:12 h, 200: <8 lux and 1000: <8 lux light-dark cycles, without scheduled sleep or activity. Neurosci Lett. 2002;329:41–44
  89. Miles LE, Raynal DM, Wilson MA. Blind man living in normal society has circadian rhythms of 24.9 hours. Science. 1977;198:421–423
  90. Mills PR, Tomkins SC, Schlangen LJ. The effect of high correlated colour temperature office lighting on employee well-being and work performance. J Circadian Rhythms. 2007;5:2
  91. Mishima K, Okawa M, Shimizu T, et al. Diminished melatonin secretion in the elderly caused by insufficient environmental illumination. J Clin Endocrinol Metab. 2001;86:129–134
  92. Mukae H, Sato M. The effect of color temperature of lighting sources on the autonomic nervous functions. Ann Physiol Anthropol. 1992;11:533–538
  93. Nguyen-Tri D, Overbury O, Faubert J. The role of lenticular senescence in age-related color vision changes. Invest Ophthalmol Vis Sci. 2003;44:3698–3704
  94. Nilsson SE. Are there advantages in implanting a yellow IOL to reduce the risk of AMD?. Acta Ophthalmol Scand. 2004;82:123–125
  95. Niwa K, Yoshino Y, Okuyama F, et al. Effects of tinted intraocular lens on contrast sensitivity. Ophthalmic Physiol Opt. 1996;16:297–302
  96. Nolan JM, O'Reilly P, Loughman J, et al. Augmentation of macular pigment following implantation of blue light–filtering intraocular lenses at the time of cataract surgery. Invest Ophthalmol Vis. 2009;50:4777–4785
  97. Ohara M, Kawashima Y, Katoh O, et al. Blue light inhibits the growth of B16 melanoma cells. Jpn J Cancer Res. 2002;93:551–558
  98. Ohara M, Kawashima Y, Watanabe H, et al. Effects of blue-light-exposure on growth of extracorporeally circulated leukemic cells in rats with leukemia induced by 1-ethyl-1-nitrosourea. Int J Mol Med. 2002;10:407–411
  99. Olson MD, Miller KM. Implanting a clear intraocular lens in one eye and a yellow lens in the other eye: a case series. Am J Ophthalmol. 2006;141:957–958
  100. Pandita D, Raj SM, Vasavada VA, et al. Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. J Cataract Refract Surg. 2007;33:603–610
  101. Partonen T, Lonnqvist J. Bright light improves vitality and alleviates distress in healthy people. J Affect Disord. 2000;57:55–61
  102. Patel AS, Dacey DM. Relative effectiveness of a blue light-filtering intraocular lens for photoentrainment of the circadian rhythm. J Cataract Refract Surg. 2009;35:529–539
  103. Perreau-Lenz S, Kalsbeek A, Garidou ML, et al. Suprachiasmatic control of melatonin synthesis in rats: inhibitory and stimulatory mechanisms. Eur J Neurosci. 2003;17:221–228
  104. Phipps-Nelson J, Redman JR, Dijk DJ, et al. Daytime exposure to bright light, as compared to dim light, decreases sleepiness and improves psychomotor vigilance performance. Sleep. 2003;26:695–700
  105. Pierre A, Wittich W, Faubert J, et al. Luminance contrast with clear and yellow-tinted intraocular lenses. J Cataract Refract Surg. 2007;33:1248–1252
  106. Rea MS, Figueiro MG, Bullough JD, et al. A model of phototransduction by the human circadian system. Brain Res Brain Res Rev. 2005;50:213–228
  107. Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-control Study Group. Arch Ophthalmol. 1992;110:1701–1708
  108. Rosen ES. A l'oeil malade la lumiere nuit. J Cataract Refract Surg. 2005;31:2237–2238
  109. Rozanowska M, Jarvis-Evans J, Korytowski W, et al. Blue light-induced reactivity of retinal age pigment. In vitro generation of oxygen-reactive species. J Biol Chem. 1995;270:18825–18830
  110. Schefrin BE, Tregear SJ, Harvey LO, et al. Senescent changes in scotopic contrast sensitivity. Vision Res. 1999;39:3728–3736
  111. Schmidt-Pokrzywniak A, Stang A, Bornfeld N, et al. Risk of uveal melanoma. Ophthalmology. 2007;114:1418
  112. Schwiegerling J. Blue-light-absorbing lenses and their effect on scotopic vision. J Cataract Refract Surg. 2006;32:141–144
  113. Scilley K, Jackson GR, Cideciyan AV, et al. Early age-related maculopathy and self-reported visual difficulty in daily life. Ophthalmology. 2002;109:1235–1242
  114. Shah CP, Weis E, Lajous M, et al. Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis. Ophthalmology. 2005;112:1599–1607
  115. Shah CP, Weis E, Lajous M, et al. Blue light exposure and uveal melanoma. Ophthalmology. 2006;113:1062
  116. Singh AD, Rennie IG, Seregard S, et al. Sunlight exposure and pathogenesis of uveal melanoma. Surv Ophthalmol. 2004;49:419–428
  117. Singh AD, Bergman L, Seregard S. Uveal melanoma: epidemiologic aspects. Ophthalmol Clin North Am. 2005;18:75–84
  118. Skene DJ, Lockley SW, Thapan K, et al. Effects of light on human circadian rhythms. Reprod Nutr Dev. 1999;39:295–304
  119. Sletten TL, Revell VL, Middleton B, et al. Age-related changes in acute and phase-advancing responses to monochromatic light. J Biol Rhythms. 2009;24:73–84
  120. Sliney DH, Wolbarsht ML. Safety with Lasers and Other Optical Sources: A Comprehensive Handbook. New York: Plenum Press; 1980;
  121. Sparrow J, Miller AS, Zhou J. Blue light-absorbing intraocular lens and retinal pigment epithelium protection in vitro. J Cataract Refract Surg. 2004;30:873–878
  122. Sparrow JR, Nakanishi K, Parish CA. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:1981–1989
  123. St Hilaire MA, Gronfier C, Zeitzer JM, et al. A physiologically based mathematical model of melatonin including ocular light suppression and interactions with the circadian pacemaker. J Pineal Res. 2007;43:294–304
  124. Stark WS. Photopic sensitivities to ultraviolet and visible wavelengths and the effects of the macular pigments in human aphakic observers. Curr Eye Res. 1987;6:631–638
  125. Steen R, Whitaker D, Elliott DB, Wi , et al. Effect of filters on disability glare. Ophthalmic Physiol Opt. 1993;13:371–376
  126. Stockman A, Sharpe LT, Merbs S, et al. Spectral sensitivities of human cone visual pigments determined in vivo and in vitro. Methods Enzymol. 2000;316:626–650
  127. Sturr JF, Zhang L, Taub HA, et al. Psychophysical evidence for losses in rod sensitivity in the aging visual system. Vision Res. 1997;37:475–481
  128. Sutter FK, Menghini M, Barthelmes D, et al. Is pseudophakia a risk factor for neovascular age-related macular degeneration?. Invest Ophthalmol Vis Sci. 2007;48:1472–1475
  129. Taylor HR, West S, Munoz B, et al. The long-term effects of visible light on the eye. Arch Ophthalmol. 1992;110:99–104
  130. Thapan K, Arendt J, Skene DJ. An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans. J Physiol. 2001;535:261–267
  131. Tomany SC, Cruickshanks KJ, Klein R, et al. Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol. 2004;122:750–757
  132. Ts'o MO, La Piana FG, Appleton B. The human fovea after sungazing. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:OP677
  133. Turner PL, Mainster MA. Circadian photoreception: ageing and the eye's important role in systemic health. Br J Ophthalmol. 2008;92:1439–1444
  134. van de Kraats J, van Norren D. Sharp cutoff filters in intraocular lenses optimize the balance between light reception and light protection. J Cataract Refract Surg. 2007;33:879–887
  135. Van Gelder RN. Non-visual photoreception: sensing light without sight. Curr Biol. 2008;18:R38–R39
  136. Vandewalle G, Gais S, Schabus M, et al. Wavelength-dependent modulation of brain responses to a working memory task by daytime light exposure. Cereb Cortex. 2007;17:2788–2795
  137. Wald G, Brown PK. Human rhodopsin. Science. 1958;127:222–226
  138. Weale RA. Guest editorial: notes on the macular pigment. Ophthalmic Physiol Opt. 2007;27:1–10
  139. Werner JS. Night vision in the elderly: consequences for seeing through a “blue filtering” intraocular lens. Br J Ophthalmol. 2005;89:1518–1521
  140. Westheimer G. The Maxwellian view. Vision Res. 1966;6:669–682
  141. Wirtitsch MG, Schmidinger G, Prskavec M, et al. Influence of blue-light-filtering intraocular lenses on color perception and contrast acuity. Ophthalmology. 2009;116:39–45
  142. Xu L, Li Y, Zheng Y, et al. Associated factors for age related maculopathy in the adult population in China: the Beijing eye study. Br J Ophthalmol. 2006;90:1087–1090
  143. Yang HC, Chung SK, Baek NH. Decentration, tilt, and near vision of the array multifocal intraocular lens. J Cataract Refract Surg. 2000;26:586–589
  144. Yang Y, Thompson K, Burns SA. Pupil location under mesopic, photopic, and pharmacologically dilated conditions. Invest Ophthalmol Vis Sci. 2002;43:2508–2512
  145. Yannuzzi LA, Fisher YL, Slakter JS, et al. Solar retinopathy. A photobiologic and geophysical analysis. Retina. 1989;9:28–43
  146. Zaidi MR, Day CP, Merlino G. From UVs to metastases: modeling melanoma initiation and progression in the mouse. J Invest Dermatol. 2008;128:2381–2391
  147. Zhao H, Mainster MA. The effect of chromatic dispersion on pseudophakic optical performance. Br J Ophthalmol. 2007;91:1225–1229

 Dr. Mainster is a consultant for Abbott Medical Optics, Iridex, and Ocular Instruments Corporations. Dr. Turner has no personal financial interest. Neither author has a proprietary interest in any product mentioned or concept discussed in this article.

PII: S0039-6257(09)00205-7

doi: 10.1016/j.survophthal.2009.07.006

Survey of Ophthalmology
Volume 55, Issue 3 , Pages 272-283 , May 2010

Article Tools

* Image Usage & Resolution